Barcelona, Spain

Kim Pedersen


 

Average Co-Inventor Count = 5.5

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2013-2014

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovator Kim Pedersen: Advancements in Cancer Diagnostics

Introduction

Kim Pedersen, a prominent inventor based in Barcelona, Spain, has made significant contributions to the field of cancer diagnostics through his innovative work. With two patents to his name, his inventions focus on improving methods for diagnosing and treating cancers that express the HER2 receptor.

Latest Patents

Kim Pedersen’s recent patents include antibodies against the HER2 truncated variant CTF-611. This invention outlines a method for diagnosing and treating cancers that express the HER2 receptor by providing antibodies or fragments that recognize specific epitopes related to the truncated form CTF-611. The innovative approach allows for the differentiation between various forms of the HER2 receptor, thereby enhancing diagnostic accuracy. The patent also details a procedure for detecting the presence of this truncated form in patient samples, which is crucial for effective cancer diagnosis.

Another significant patent he holds describes a method for diagnosing cancers expressing the HER2 receptor or its truncated variants. Similar to his first invention, this patent focuses on the use of antibodies that recognize specific epitopes defined by the amino acid sequences included in SEQ ID NO: 2 and SEQ ID NO: 1, further emphasizing the importance of precision in cancer treatment and diagnosis.

Career Highlights

Throughout his career, Kim has worked with notable research institutions such as the Fundació Privada Institut de Recerca Hospital Universitari Vall Hebron and the Fundació Privada Institució Catalana de Recerca i Estudis Avançats. These affiliations have allowed him to engage in groundbreaking research, significantly contributing to the medical community’s understanding of cancer and the HER2 receptor.

Collaborations

Kim Pedersen has collaborated with esteemed colleagues, including Joaquin Arribas Lopez and Pier-Davide Angellini. This collaborative spirit showcases the importance of teamwork in advancing research and developing innovative solutions within the field of cancer diagnostics.

Conclusion

Kim Pedersen stands out as a dedicated inventor whose work in cancer diagnostics has the potential to change lives. His patents reflect cutting-edge research aimed at improving cancer diagnosis and treatment, demonstrating his commitment to innovation in healthcare. As he continues to explore new frontiers in this essential field, the impact of his contributions is sure to be felt for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…